Physician profile
Suhel Kotwal
NPI 1942513239
$13,801.05
in general payments reported to CMS, 2019-2025
11 companies · $847 in 2025
The $847 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,036 · 2020: $3,607 · 2021: $4,304 · 2022: $2,020 · 2023: $1,298 · 2024: $690 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,988 · Travel and Lodging: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,987.87 |
| Travel and Lodging | $846.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,710.80 | 2020-2025 | Rosa, Taperloc, Persona |
| Globus Medical, INC. | $3,949.74 | 2021-2024 | Sable, Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $3,870.34 | 2019-2025 | Mako, Cascadia Interbody System, Pangea |
| Encore Medical, LP | $426.28 | 2020 | |
| Arthrex, INC. | $242.68 | 2025 | |
| Medtronic, INC. | $148.30 | 2022-2023 | Unid_pass |
| Next Science LLC | $132.07 | 2021 | |
| Abbott Laboratories | $117.45 | 2022 | |
| Titan Surgical Group, LLC | $108.48 | 2025 | |
| Biocomposites INC | $73.62 | 2019-2020 | |
| Depuy Synthes Sales INC. | $21.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhel Kotwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.